ING3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05525
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: MLYLEDYLEMIEQLPMDLRDRFTEMREMDLQVQNAMDQLEQRVSEFFMNAKKNKPEWREEQMASIKKDYYKALEDADEKVQLANQI
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ING3 Antibody
Immunocytochemistry/ Immunofluorescence: ING3 Antibody [NBP3-05525]
Immunocytochemistry/Immunofluorescence: ING3 Antibody [NBP3-05525] - Staining of human cell line HEK 293 shows localization to nucleus.Applications for ING3 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, containing 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ING3
Alternate Names
FLJ20089, ING2, inhibitor of growth family, member 3, inhibitor of growth protein 3, MEAF4, P47, p47ING3Eaf4
Gene Symbol
ING3
Additional ING3 Products
Product Documents for ING3 Antibody
Product Specific Notices for ING3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...